-
Je něco špatně v tomto záznamu ?
An enzymatic assay based on luciferase Ebola virus-like particles for evaluation of virolytic activity of antimicrobial peptides
M. Peskova, Z. Heger, P. Janda, V. Adam, V. Pekarik,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- anionty MeSH
- antivirové látky farmakologie MeSH
- hemoragická horečka Ebola prevence a kontrola virologie MeSH
- kationické antimikrobiální peptidy farmakologie MeSH
- Lentivirus účinky léků genetika MeSH
- lidé MeSH
- liposomy chemie MeSH
- peptidy farmakologie MeSH
- virus Ebola účinky léků patogenita MeSH
- VLP vakcíny MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Antimicrobial peptides are currently considered as promising antiviral compounds. Current assays to evaluate the effectivity of peptides against enveloped viruses based on liposomes or hemolysis are encumbered by the artificial nature of liposomes or distinctive membrane composition of used erythrocytes. We propose a novel assay system based on enzymatic Ebola virus-like particles containing sensitive luciferase reporter. The assay was validated with several cationic and anionic peptides and compared with lentivirus inactivation and hemolytic assays. The assay is sensitive and easy to perform in standard biosafety level laboratory with potential for high-throughput screens. The use of virus-like particles in the assay provides a system as closely related to the native viruses as possible eliminating some issues associated with other more artificial set ups. We have identified CAM-W (KWKLWKKIEKWGQGIGAVLKWLTTWL) as a peptide with the greatest antiviral activity against infectious lentiviral vectors and filoviral virus-like particles.
Central European Institute of Technology Brno University of Technology 616 00 Brno Czechia
Central European Institute of Technology Masaryk University Kamenice 5 625 00 Brno Czechia
Department of Chemistry and Biochemistry Mendel University 613 00 Brno Czechia
Institute of Physiology Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016841
- 003
- CZ-PrNML
- 005
- 20180521134943.0
- 007
- ta
- 008
- 180515s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.peptides.2016.12.015 $2 doi
- 035 __
- $a (PubMed)28012857
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Peskova, Marie $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 625 00 Brno, Czechia. Electronic address: m.peskova@mail.muni.cz.
- 245 13
- $a An enzymatic assay based on luciferase Ebola virus-like particles for evaluation of virolytic activity of antimicrobial peptides / $c M. Peskova, Z. Heger, P. Janda, V. Adam, V. Pekarik,
- 520 9_
- $a Antimicrobial peptides are currently considered as promising antiviral compounds. Current assays to evaluate the effectivity of peptides against enveloped viruses based on liposomes or hemolysis are encumbered by the artificial nature of liposomes or distinctive membrane composition of used erythrocytes. We propose a novel assay system based on enzymatic Ebola virus-like particles containing sensitive luciferase reporter. The assay was validated with several cationic and anionic peptides and compared with lentivirus inactivation and hemolytic assays. The assay is sensitive and easy to perform in standard biosafety level laboratory with potential for high-throughput screens. The use of virus-like particles in the assay provides a system as closely related to the native viruses as possible eliminating some issues associated with other more artificial set ups. We have identified CAM-W (KWKLWKKIEKWGQGIGAVLKWLTTWL) as a peptide with the greatest antiviral activity against infectious lentiviral vectors and filoviral virus-like particles.
- 650 _2
- $a anionty $7 D000838
- 650 _2
- $a kationické antimikrobiální peptidy $x farmakologie $7 D023181
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a virus Ebola $x účinky léků $x patogenita $7 D029043
- 650 _2
- $a hemoragická horečka Ebola $x prevence a kontrola $x virologie $7 D019142
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Lentivirus $x účinky léků $x genetika $7 D016086
- 650 _2
- $a liposomy $x chemie $7 D008081
- 650 _2
- $a peptidy $x farmakologie $7 D010455
- 650 _2
- $a VLP vakcíny $7 D058425
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University, 613 00 Brno, Czechia; Central European Institute of Technology (CEITEC), Brno University of Technology, 616 00 Brno, Czechia. Electronic address: zbynek.heger@mendelu.cz.
- 700 1_
- $a Janda, Petr $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 625 00 Brno, Czechia. Electronic address: 323853@mail.muni.cz.
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University, 613 00 Brno, Czechia; Central European Institute of Technology (CEITEC), Brno University of Technology, 616 00 Brno, Czechia. Electronic address: vojtech.adam@mendelu.cz.
- 700 1_
- $a Pekarik, Vladimir $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 625 00 Brno, Czechia; Institute of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czechia. Electronic address: pekarikv@mail.muni.cz.
- 773 0_
- $w MED00003749 $t Peptides $x 1873-5169 $g Roč. 88, č. - (2017), s. 87-96
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28012857 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180521135125 $b ABA008
- 999 __
- $a ok $b bmc $g 1300465 $s 1013681
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 88 $c - $d 87-96 $e 20161222 $i 1873-5169 $m Peptides $n Peptides $x MED00003749
- LZP __
- $a Pubmed-20180515